The FDA approved the first treatment for eosinophilic esophagitis, a chronic immune disorder, in adults and pediatric patients (12 years and older weighing at least 40 kilograms, which is about 88 pounds).
Read more: FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder